Hormone Therapy
Oxytocin + COPE Therapy for Alcoholism and PTSD
Recruiting0 awardsPhase 2
Charleston, South Carolina
This trial will compare oxytocin to a placebo in reducing symptoms of alcohol use disorder and post-traumatic stress disorder in veterans receiving COPE therapy. Brain scans will be used to examine potential mechanisms of change.
Oxytocin for PTSD
Recruiting0 awardsPhase 2
San Francisco, California
This trial will examine the ability of oxytocin to reduce PTSD symptoms, compared to placebo, when combined with Prolonged Exposure therapy. The study will be conducted with Veterans and has the potential to significantly improve mental health care among Veterans.
Hormone Therapy
Oxytocin Nasal Spray for Autism
Recruiting0 awardsPhase 2
Boston, Massachusetts
This trial tests if giving oxytocin through a nasal spray can improve bone health in children with autism. Children with autism often have weaker bones and lower levels of oxytocin. The study aims to see if oxytocin can help make their bones stronger. Oxytocin has been investigated for its potential to treat social deficits in autism spectrum disorders, with various studies exploring its effects on social behavior and brain function.
Popular Filters
Trials With No Placebo
Hormone Therapy
Oxytocin Nasal Spray for Frontotemporal Dementia
Recruiting3 awardsPhase 2
Los Angeles, California
This trial is testing the safety and effects of oxytocin given as a nasal spray to people with frontotemporal dementia or Pick's disease, compared to a placebo. Approximately 112 patients will be enrolled at 15 centers in the US and Canada, and will be given either oxytocin or the placebo nasal spray. The trial will happen in two phases, first testing different doses of oxytocin to see which is most effective, and then randomly assigning patients in the second phase to either the most effective dose of oxytocin or the placebo.
Hormone Therapy
Deuterated Oxytocin for Postpartum Hemorrhage
Recruiting1 awardPhase 2
Chicago, Illinois
This trial will help researchers understand why oxytocin, the first-line drug to prevent uterine atony, sometimes fails. Participants will receive a single dose of deuterium-labeled oxytocin, followed by an infusion of unlabeled oxytocin. Blood samples will be taken to measure plasma concentrations of both oxytocins over time.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.